Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIDAS: Milrinone for Prevention of Post-ligation Cardiac Syndrome
NCT06679855Phase 3Recruiting
- Sponsor
- NICHD Neonatal Research Network
- Start
- Jun 2025
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of milrinone in post-ligation cardiac syndrome (PLCS), sponsored by NICHD Neonatal Research Network. Started Jun 2025; status: recruiting.
02
Drugs
milrinone
03
Conditions
post-ligation cardiac syndrome (PLCS)
Beyond the preview
Go deeper on NCT06679855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06679855.